The report on the Global Gastroesophageal Reflux Disease Therapeutics Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Drivers
- Increase in aging population
- Growing prevalence of gastroesophageal reflux disease
Restraints
- Patent expiry and weak drug pipeline
The report includes a detailed analysis of value chain in order to provide a holistic view of the gastroesophageal reflux disease therapeutics market. Value chain analysis comprises of detailed evaluation of the roles of various players involved in the gastroesophageal reflux disease therapeutics industry, from raw material suppliers to end-users.
Gastroesophageal reflux disease therapeutics market attractiveness analysis has been included in order to analyze the application segments that are estimated to be lucrative during the forecast period on the basis of their market size and growth rate. Attractiveness of the market has been derived from market size, profit margin, growth rate, availability of raw materials, competition, and other factors such as social and legal constraints.
The gastroesophageal reflux disease therapeutics market has further been segmented based on product types such as antacids, proton pump inhibitors, h2 receptor blocker, pro kinetic agents, dopamine receptor antagonist, endocinch, stretta, esophyx, transoral incisionless fundoplication and linx. The study provides forecast and estimates market for each product type in terms of revenue during the forecast period. Each product type has been further analyzed based on regional and country levels in terms of revenue.
The gastroesophageal reflux disease therapeutics market has been segmented based on distribution channel such as hospital pharmacy, drug stores, general stores and supermarkets. The study provides forecast and estimates market for each distribution channel in terms of revenue during the forecast period. Each distribution channel has been further analyzed based on regional and country levels in terms of revenue.
In terms of geography, the gastroesophageal reflux disease therapeutics market has been segmented into regions such as North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The study provides a detailed view of country-level aspects of the market on the basis of application segments and estimates the market in terms of revenue during the forecast period.
The report also offers a competitive landscape of the overall market with company profiles of players such as:
- AstraZeneca
- Addex Pharmaceuticals
- Vecam
- Medigus
- Peer Medical
- EndoGastric Solutions
- Eisai Co., Ltd
- Takeda Pharmaceutical Company Limited
- RaQualia Pharma Inc.
- Reviva Pharmaceuticals Inc.
- Rottapharm Madaus
- Torax Medical
- Mederi Therapeutics
- Aros Pharma
A detailed description of the each company has been included and includes information in terms of headquarters, inception, stock listing, upcoming capacities, key mergers & acquisitions, financial overview, and recent developments and provides a thorough idea about the competitive positioning of market players. The report also provides gastroesophageal reflux disease therapeutics market's mergers/acquisitions, partnerships, collaborations, new product launches, new product developments and other industry developments.
SEGMENTATIONS IN REPORT:
Gastroesophageal Reflux Disease Therapeutics Market Analysis By Product Type:
- Antacids
- Proton pump inhibitors
- H2 receptor blocker
- Pro kinetic agents
- Dopamine receptor antagonist
- EndoCinch
- Stretta
- EsophyX
- Transoral Incisionless fundoplication
- Linx
Gastroesophageal Reflux Disease Therapeutics Market Analysis By Distribution Channel:
- Hospital pharmacy
- Drug stores
- General stores
- Supermarkets
Gastroesophageal Reflux Disease Therapeutics Market Analysis By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East And Africa
The Global Gastroesophageal Reflux Disease Therapeutics Market has been exhibited in detail in the following chapters -
Chapter 1 Gastroesophageal Reflux Disease Therapeutics Market Preface
Chapter 2 Executive Summary
Chapter 3 Gastroesophageal Reflux Disease Therapeutics Industry Analysis
Chapter 4 Gastroesophageal Reflux Disease Therapeutics Market Value Chain Analysis
Chapter 5 Gastroesophageal Reflux Disease Therapeutics Market Analysis By Product Type
Chapter 6 Gastroesophageal Reflux Disease Therapeutics Market Analysis By Distribution Channel
Chapter 7 Gastroesophageal Reflux Disease Therapeutics Market Analysis By Geography
Chapter 8 Competitive Landscape Of Gastroesophageal Reflux Disease Therapeutics Companies
Chapter 9 Company Profiles Of Gastroesophageal Reflux Disease Therapeutics Industry
METHODOLOGY:
Combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific Details on methodology used for this report can be provided on demand.